University of Illinois researchers quantify drug delivery from nanoparticles inside a cell

October 03, 2016

For the first time, researchers from the University of Illinois at Urbana-Champaign have demonstrated that the success of delivery of drugs from nanoparticles can be quantified inside a cell.

"We can precisely tell how much drug has been released from the carrier at a given time point," stated Dipanjan Pan, assistant professor of Bioengineering at Illinois. "To the best of our knowledge, this represents the first example of a one-step, facile procedure to synthesize pro-drug-passivated carbon nanoparticles. The result is significant and may help eventually to increase the efficacy of the therapy and help us better understand what drives the cellular entry of nanoparticles and drug release.

"Although nanotechnology is a nascent field, its potential for detecting and treating human disease is fascinating," Pan added. "But, in order for these exciting technologies covering tiny agents to progress toward human use, we need to fully understand the mechanisms underlying their intracellular uptake within our complex biological networks. It is also of great importance to find a robust way to monitor the drug release to gauge the success of the process."

Pan explained that current drug delivery platforms suffer from major burdens (e.g., evading the immune system to reach the target tissue). Since these delivery vehicles encounter multiple barriers en route to their target, premature release of the drugs from the cargo often leads to unsuccessful outcomes.

"A fundamental understanding of the basic science of particulate transport will result in succeeding the ability to control and manipulate drug delivery," Pan said. "In this work, we ask critical questions such as, 'How much drug is being released from the nanoparticle once the particles enter the cells?' 'Is there a way to track the progress of this delivery process?' 'How could we quantify the amount of the drug that has already been released from the particle and how much is still retained within?'"

In the past, researchers have shown that the release of drug can be studied in test tubes; however, the quantification is not trivial in the presence of a living cell.

"Spatial and spectral information of a nanocarrier and its payload is crucial for the advancement of luminescence-based imaging, disease detection, and treatment in complex biological environment," said Santosh Misra, a postdoctoral associate at Illinois and first author of the paper appearing in Advanced Functional Materials. "For the first time, we are showing that, by using a hyperspectral imaging technique, this can be achieved. Our results showed that we can precisely map the amount of the drug that has been released from the particle at a given point of time. We also throw light into the mechanistic pathway of the nanoparticle, by which it gets internalized within a cancer cell."

Pan's research group designed three systems comprising spherical, zwitterionic (a neutral molecule with both positive and negative electrical charges) and phospholipid-stabilized nanoparticles as a model system for delivering fluorescent and non-fluorescent drugs -- demonstrating the concept with an FDA-approved anticancer drug on breast cancer cells.

"The results showed that the nanoparticles and therapeutic agents can be mapped and measured simultaneously, barring the requirement of a dye, thus providing new avenues in spatiotemporal characterization and synchronous detection and quantification of payload and carrier," Pan said. "I anticipate that our results will help the biomedical community to rethink the level of control needed when working with drug delivery carriers, and eventually a much (more) efficacious therapeutic outcome will be envisioned."
-end-
In addition to Misra and Pan, graduate students Fatemeh Ostadhossein, Enrique Daza, and E. V. Johnson co-authored the paper, "Hyperspectral Imaging Offers Visual and Quantitative Evidence of Drug Release from Zwitterionic-Phospholipid-NanoCarbon when Concurrently Tracked in Three-dimensional Intracellular Space," which is available online at http://onlinelibrary.wiley.com/doi/10.1002/adfm.201602966/abstract;jsessionid=F461D8F88A37EDB0DAE8760E60A41532.f04t02#.

University of Illinois College of Engineering

Related Nanoparticles Articles from Brightsurf:

An ionic forcefield for nanoparticles
Nanoparticles are promising drug delivery tools but they struggle to get past the immune system's first line of defense: proteins in the blood serum that tag potential invaders.

Phytoplankton disturbed by nanoparticles
Products derived from nanotechnology are efficient and highly sought-after, yet their effects on the environment are still poorly understood.

How to get more cancer-fighting nanoparticles to where they are needed
University of Toronto Engineering researchers have discovered a dose threshold that greatly increases the delivery of cancer-fighting drugs into a tumour.

Nanoparticles: Acidic alert
Researchers of Ludwig-Maximilians-Universitaet (LMU) in Munich have synthesized nanoparticles that can be induced by a change in pH to release a deadly dose of ionized iron within cells.

3D reconstructions of individual nanoparticles
Want to find out how to design and build materials atom by atom?

Directing nanoparticles straight to tumors
Modern anticancer therapies aim to attack tumor cells while sparing healthy tissue.

Sweet nanoparticles trick kidney
Researchers engineer tiny particles with sugar molecules to prevent side effect in cancer therapy.

A megalibrary of nanoparticles
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles.

Dialing up the heat on nanoparticles
Rapid progress in the field of metallic nanotechnology is sparking a science revolution that is likely to impact all areas of society, according to professor of physics Ventsislav Valev and his team at the University of Bath in the UK.

Illuminating the world of nanoparticles
Scientists at the Okinawa Institute of Science and Technology Graduate University (OIST) have developed a light-based device that can act as a biosensor, detecting biological substances in materials; for example, harmful pathogens in food samples.

Read More: Nanoparticles News and Nanoparticles Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.